Advanced magnetic resonance spectroscopic neuroimaging: Experts' consensus recommendations.

Autor: Maudsley AA; Department of Radiology, Miller School of Medicine, University of Miami, Miami, Florida, USA., Andronesi OC; Department of Radiology, Massachusetts General Hospital, Athinoula A. Martinos Center for Biomedical Imaging, Harvard Medical School, Boston, Massachusetts., Barker PB; The Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, and the Kennedy Krieger Institute, F.M. Kirby Center for Functional Brain Imaging, Baltimore, Maryland., Bizzi A; Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy., Bogner W; High Field MR Center, Department of Biomedical Imaging and Image-guided Therapy, Medical University Vienna, Vienna, Austria., Henning A; Max Planck Institute for Biological Cybernetics, Tübingen, Germany.; Advanced Imaging Research Center, University of Texas Southwestern Medical Center, Dallas, Texas., Nelson SJ; Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California., Posse S; Department of Neurology, University of New Mexico, Albuquerque, New Mexico., Shungu DC; Department of Neuroradiology, Weill Cornell Medical College, New York, New York., Soher BJ; Department of Radiology, Duke University Medical Center, Durham, North Carolina.
Jazyk: angličtina
Zdroj: NMR in biomedicine [NMR Biomed] 2021 May; Vol. 34 (5), pp. e4309. Date of Electronic Publication: 2020 Apr 29.
DOI: 10.1002/nbm.4309
Abstrakt: Magnetic resonance spectroscopic imaging (MRSI) offers considerable promise for monitoring metabolic alterations associated with disease or injury; however, to date, these methods have not had a significant impact on clinical care, and their use remains largely confined to the research community and a limited number of clinical sites. The MRSI methods currently implemented on clinical MRI instruments have remained essentially unchanged for two decades, with only incremental improvements in sequence implementation. During this time, a number of technological developments have taken place that have already greatly benefited the quality of MRSI measurements within the research community and which promise to bring advanced MRSI studies to the point where the technique becomes a true imaging modality, while making the traditional review of individual spectra a secondary requirement. Furthermore, the increasing use of biomedical MR spectroscopy studies has indicated clinical areas where advanced MRSI methods can provide valuable information for clinical care. In light of this rapidly changing technological environment and growing understanding of the value of MRSI studies for biomedical studies, this article presents a consensus from a group of experts in the field that reviews the state-of-the-art for clinical proton MRSI studies of the human brain, recommends minimal standards for further development of vendor-provided MRSI implementations, and identifies areas which need further technical development.
(© 2020 John Wiley & Sons, Ltd.)
Databáze: MEDLINE
Externí odkaz: